| P50 | author | Annemieke De Jong | Q42857739 |
| P2093 | author name string | S H van der Burg | |
| | R Offringa | |
| | T O'Neill | |
| | S E Chisholm | |
| | J K Hickling | |
| | A Y Khan | |
| | J A Dobson | |
| | J A St Clair Roberts | |
| | K M C Kwappenberg | |
| | L C Jack | |
| | N R Whittle | |
| P2860 | cites work | Antigen-specific immunotherapy for murine lung metastatic tumors expressing human papillomavirus type 16 E7 oncoprotein | Q77180605 |
| | The makings of a tumor rejection antigen | Q33748013 |
| | Immunization with nonstructural proteins E1 and E2 of cottontail rabbit papillomavirus stimulates regression of virus-induced papillomas | Q35830690 |
| | Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens | Q40703649 |
| | Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors | Q41304280 |
| | Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells | Q41532466 |
| | Properties of a non-tumorigenic human cervical keratinocyte cell line | Q42813651 |
| | Immunological events in regressing genital warts | Q43760914 |
| | A recombinant vaccinia virus containing the papilloma E2 protein promotes tumor regression by stimulating macrophage antibody-dependent cytotoxicity | Q44005009 |
| | The global burden of cancer | Q44698451 |
| | Incidence of venereal warts in human immunodeficiency virus-infected and uninfected women | Q45784968 |
| | Natural history of cervicovaginal papillomavirus infection in young women. | Q50909200 |
| | Natural T-helper immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: identification of 3 human leukocyte antigen class II-restricted epitopes. | Q52020790 |
| | Viruses in human cancers | Q56486194 |
| | Immunohistologic analysis of the phenomenon of spontaneous regression of numerous flat warts | Q70145809 |
| | Prophylactic and therapeutic vaccination against a mucosal papillomavirus | Q70459386 |
| | Human papillomavirus infection is transient in young women: a population-based cohort study | Q72133275 |
| | Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions | Q72680272 |
| | Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasia | Q73689490 |
| | Phase I safety and antigenicity of TA-GW: a recombinant HPV6 L2E7 vaccine for the treatment of genital warts | Q74607911 |
| P433 | issue | 29-30 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3456-3464 | |
| P577 | publication date | 2002-10-01 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Enhancement of human papillomavirus (HPV) type 16 E6 and E7-specific T-cell immunity in healthy volunteers through vaccination with TA-CIN, an HPV16 L2E7E6 fusion protein vaccine | |
| P478 | volume | 20 | |